Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 12 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2002Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanismFindlay, D.; Raggatt, L.; Bouralexis, S.; Hay, S.; Atkins, G.; Evdokiou, A.
2002Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to APO2L/TRIAL-induced apoptosisEvdokiou, A.; Bouralexis, S.; Atkins, G.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.
2002Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosisAtkins, G.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Labrinidis, A.; Zannettino, A.; Haynes, D.; Findlay, D.
2003Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapyBouralexis, S.; Findlay, D.; Atkins, G.; Labrinidis, A.; Hay, S.; Evdokiou, A.
2001Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAILClayer, M.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Atkins, G.; Findlay, D.
2001Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosisAtkins, G.; Evdokiou, A.; Bouralexis, S.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.
2002Zoledronate is anabolic for human osteoblast-like cellsAtkins, G.; Pan, B.; Findlay, D.; To, L.; Evdokiou, A.; Labrinidis, A.; Bouralexis, S.; Zannettino, A.; American Society for Bone and Mineral Research. Conference (24th : 2002 : San Antonio, Texas)
2000Expression of osteoclast differentiation signals by stromal elements of giant cell tumorsAtkins, G.; Haynes, D.; Graves, S.; Evdokiou, A.; Hay, S.; Bouralexis, S.; Findlay, D.
2006The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAILButler, L.; Liapis, V.; Bouralexis, S.; Welldon, K.; Hay, S.; Thai, L.; Labrinidis, A.; Tilley, W.; Findlay, D.; Evdokiou, A.
2005Death to the bad buys: Targeting cancer via Apo2L/TRAILBouralexis, S.; Findlay, D.; Evdokiou, A.